SC 13D

Company

Jasper Therapeutics, Inc.

Filed

October 4, 2021

Accession Number

0000905718-21-001266

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →